SCHEMBL7400071

SCHEMBL7400071

COC(=O)CNc1nc(OC)ns1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
PPARG P37231 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ALDH1A1 P00352 4/20 0.34
KMT2A Q03164 4/20 0.34
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34
CA9 Q16790 3/20 0.34
CA14 Q9ULX7 3/20 0.34
MEN1 O00255 3/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 2/20 0.33
PTGS2 P35354 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405055 0.81 L3MBTL1 (0.36) GAAPPARGNCOA2NCOA1RXFP1
SCHEMBL7400635 0.74 SMN1; SMN2 (0.34) ALDH1A1CA12CA1CA2CA9
SCHEMBL17667391 0.74 ADORA3 (0.41) RXFP1KMT2AMEN1POLBMAPT
SCHEMBL24491102 0.72 ADORA3 (0.40) RXFP1ALDH1A1KMT2AMEN1MAPT
SCHEMBL7405306 0.72 MAPT (0.41) RXFP1ALDH1A1KMT2AMEN1MAPT
SCHEMBL7395476 0.72 CASP2 (0.46) RXFP1ALDH1A1KMT2AMEN1POLB
SCHEMBL7400883 0.72 MAPT (0.41) RXFP1ALDH1A1KMT2ACA1CA2
SCHEMBL22436168 0.71 ADORA3 (0.40) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL7405214 0.71 GAA (0.40) GAAALDH1A1KMT2AMEN1POLB
SCHEMBL7637979 0.69 NPC1 (0.31) ALDH1A1MAPTNPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
WO-2001090095-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2001-11-29 WO disclosed
US-6162791-A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes APOTEX INC. (CA) 2000-12-19 US disclosed
EP-1058690-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2000-12-13 EP disclosed
WO-1999045027-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 1999-09-10 WO disclosed